Life Science REIT PLC
LSE:LABS
Intrinsic Value
The intrinsic value of one LABS stock under the Base Case scenario is 50.91 GBX. Compared to the current market price of 42.5 GBX, Life Science REIT PLC is Undervalued by 17%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Life Science REIT PLC
Loading...
Fundamental Analysis

Revenue & Expenses Breakdown
Life Science REIT PLC
Balance Sheet Decomposition
Life Science REIT PLC
Current Assets | 12.1m |
Cash & Short-Term Investments | 5.6m |
Receivables | 3.1m |
Other Current Assets | 3.5m |
Non-Current Assets | 389m |
Long-Term Investments | 385.2m |
Other Non-Current Assets | 3.8m |
Free Cash Flow Analysis
Life Science REIT PLC
GBP | |
Free Cash Flow | GBP |
Earnings Waterfall
Life Science REIT PLC
Revenue
|
20.3m
GBP
|
Cost of Revenue
|
-5.9m
GBP
|
Gross Profit
|
14.4m
GBP
|
Operating Expenses
|
-4.8m
GBP
|
Operating Income
|
9.6m
GBP
|
Other Expenses
|
-23.6m
GBP
|
Net Income
|
-14m
GBP
|
LABS Profitability Score
Profitability Due Diligence
Life Science REIT PLC's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
Score
Life Science REIT PLC's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
LABS Solvency Score
Solvency Due Diligence
Life Science REIT PLC's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Score
Life Science REIT PLC's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LABS Price Targets Summary
Life Science REIT PLC
According to Wall Street analysts, the average 1-year price target for LABS is 37.74 GBX with a low forecast of 37.37 GBX and a high forecast of 38.85 GBX.
Dividends
Current shareholder yield for LABS is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one LABS stock under the Base Case scenario is 50.91 GBX.
Compared to the current market price of 42.5 GBX, Life Science REIT PLC is Undervalued by 17%.